- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Incruse Ellipta and Atrovent HFA the Same Thing?
Incruse Ellipta (umeclidinium) Inhalation Powder and Atrovent HFA (ipratropium bromide HFA) are anticholinergic drugs used for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Side effects of Incruse Ellipta that are different from Atrovent HFA include upper respiratory infection, runny nose, sore throat, joint pain, muscle pain, tooth pain, bruising or dark areas of skin, chest pain, and fast or irregular heartbeat.
Side effects of Atrovent HFA that are different from Incruse Ellipta include headache, dry mouth, hoarseness, sinus pain, nausea, back pain, fever, chills, body aches, flu symptoms, blurred vision, and dizziness.
Incruse Ellipta may interact with other anticholinergic drugs.
Atrovent HFA may interact with cold or allergy medicines, medicines to treat Parkinson's disease; medicines to treat stomach problems, motion sickness, or irritable bowel syndrome; medicines to treat overactive bladder; other bronchodilators; and medicines to treat depression, anxiety, mood disorders, or mental illness.
What Are Possible Side Effects of Incruse Ellipta?
Common side effects of Incruse Ellipta include:
What Are Possible Side Effects of Atrovent HFA?
Common side effects of Atrovent HFA include:
- dry mouth
- stuffy nose
- sinus pain
- upset stomach
- back pain
- body aches
- flu symptoms
- blurred vision, and
Tell your doctor if you experience serious side effects of Atrovent HFA HFA including bronchospasm (wheezing, chest tightness, trouble breathing), eye pain, seeing halos around lights, pain or burning when you urinate, urinating less than usual or not at all, or worsening of your symptoms.
What Is Incruse Ellipta?
Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
What Is Atrovent HFA?
Atrovent HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
What Drugs Interact With Incruse Ellipta?
Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
What Drugs Interact With Atrovent HFA?
Atrovent HFA may interact with other bronchodilators. Atrovent HFA may also interact with bladder or urinary medicines, cold or allergy medicines that contain an antihistamine, medications for Parkinson's disease, or medications to treat excess stomach acid, stomach ulcer, motion sickness, or irritable bowel syndrome.
How Should Incruse Ellipta be Taken?
Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Boehringer Ingelheim Pharmaceuticals, Inc. Atrovent Product Information.